{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-001063","form_type":"8-K","ticker":"BGLC","cik":"0001737523","company_name":"BioNexus Gene Lab Corp","filed_at":"2025-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.666759+00:00","generated_at":"2026-05-26T21:28:02.425007+00:00","sec_items":["3.02","5.03","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioNexus Gene Lab creates Series Z Preferred with 5B votes to facilitate Reverse Stock Split","bullets":["Created one share of Series Z Preferred Stock with 5,000,000,000 votes, solely on Reverse Stock Split matter.","Issued to director Muhammad Azrul bin Abdul Hamid on Feb 10, 2025, exempt under Section 4(a)(2).","Series Z will vote proportionally to common shares, increasing total votes but not affecting percentage for/against.","Purpose is to ensure passage of Reverse Stock Split at upcoming Special Meeting.","Share may be cancelled by Board or automatically upon shareholder approval of Reverse Split."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-001063","json":"https://secwatch.observer/filing/0001477932-25-001063.json","markdown":"https://secwatch.observer/filing/0001477932-25-001063.md","text":"https://secwatch.observer/filing/0001477932-25-001063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225001063/0001477932-25-001063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225001063/bglc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T21:28:02.425007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d6b97a2e66fbe913a2766e7c51d8e37420d1eb8c","claim":"BioNexus Gene Lab Corp: Filed Articles of Amendment to authorize creation of Series Z Convertible Preferred Stock with special voting rights tied to a Reverse Stock Split proposal (effective 2025-02-11).","evidence_excerpt":"On February 11, 2025, the Company filed with the Wyoming Secretary of State Articles of Amendment to its Articles of Incorporation (a true and correct copy of which is attached hereto as Exhibit 3.6) (“Amendment”). The Amendment authorizes the creation of one (1) share of the Series Z Convertible Preferred Stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737523/000147793225001063/0001477932-25-001063-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-02-11"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}